Overseas customers boost China Bottles contracts

By Gareth Macdonald

- Last updated on GMT

Related tags Pharmaceutical packaging Bottle

Plastic packaging specialist China Bottles (CB) says that nearly two thirds of the $3.3m worth of contracts it signed in June were with pharmaceutical companies based outside its home territory.

CB manufacturers, markets and sells a wide range of packaging production equipment for industrial clients. The company’s technology includes high speed injection molding units for blow molding of polyethylene terephthalate (PET) and PP bottles. CB also produces plastic bottles for industrial clients on a contractual basis.

The majority of the orders, which are worth approximately three times as much as those booked in the comparable month last year, are for the supply of molding and bottle blowing machines to firms in the drug packaging sector.

CB’s overseas clients for June were from Australia, Cambodia, Sri Lanka, Kyrgyzstan, Senegal and Algeria which, Australia excluded, are all new markets for the Qingyuan-headquartered company. Entry into both the pharmaceutical sector and new territories are a key part of the company’s stated development strategy.

. Chonghui Zhao, China Bottles’ CEO, commented that: "We are pleased to see our successful entry into the pharmaceutical packaging application market as well as the expanding geographic reach of our sales and marketing network​."

"We believe that recent increases in business are a credit to our efficient manufacturing practices and superior quality products. As we are now operating at full capacity, we are currently planning expansions to our facilities to allow for further growth​," added Zhao.

Expanding Chinese drug packaging market

The remaining deals with domestic clients were dominated by orders for polypropylene (PP) bottle blowing production machines and molds for the manufacture of numerous types of pharmaceutical packaging

Within China, the demand for pharmaceutical packaging that adheres to international standards and regulations is growing as manufacturers seek ways to offer improved drug storage characteristics for their products.

Additionally in recent years, the Chinese government has sought to improve the nation's reputation with regards to quality across all aspects of industry in an effort to attract even more international customers and investment. This focus by the government is expected to translate into impressive growth of the Chinese pharmaceutical packaging industry. A recent report by The Freedonia Group predicted that the sector would grow by around12.5 per cent this year alone.

Related news

Related products

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers

Follow us


View more